Theravance Biopharma Aktie
8,90
EUR
-0,35
EUR
-3,78
%
9,39
USD
-0,30
USD
-3,10
%
Werbung
Theravance Biopharma Aktie Analyse
16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC | |
12.10.16 | Theravance Biopharma Underperform | Robert W. Baird & Co. Incorporated | |
03.02.15 | Theravance Biopharma Neutral | Robert W. Baird & Co. Incorporated |
Werbung
Werbung